Clinical Trials Directory

Trials / Unknown

UnknownNCT02998957

Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients With Severe Dyspnoea

Efficacy of Transcutaneous Electrical Stimulation at Dingchuan (EX-B1) in Hospitalized COPD Patients With Severe Dyspnoea: Patient and Assessor Blinded Randomized Placebo Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Fundació Sant Joan de Déu · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Introduction: Chronic obstructive pulmonary disease (COPD) presents with a gradual reduction and little bitterness reversible airflow causing shortness of breath, chronic cough and sputum abnormal. Patients with COPD often suffer exacerbations of their symptoms, particularly dyspnea, causing hospital admissions. Recent studies have shown that acupuncture stimulation transcutánea (AcuTENS) Dingchuan point (EX-B1) could help reduce dyspnea in patients with COPD. Objective: The aim of this study was to evaluate the possible utility of adding to the usual treatment stimulation AcuTENS in COPD patients admitted with severe dyspnea. Methodology: Patients who agree to participate will be randomly divided into two groups. The intervention group will receive a daily treatment, during the period of hospitalization, 45 minutes stimulation at acupuncture point AcuTENS Dingchuan (EX-B1), while the control group performed the same procedure with a device TENS simulated. The extent of dyspnea in both groups as well as the number of days of hospitalization and the number of drugs consumed.

Conditions

Interventions

TypeNameDescription
DEVICEAcuTENSStimulation of acupuncture point Dingchuan using transcutaneous electrical nerve stimulation (TENS) instead of needles
DEVICESham AcuTENSPortable TENS electrostimulation device with no electrical output

Timeline

Start date
2018-04-01
Primary completion
2019-06-01
Completion
2019-09-01
First posted
2016-12-21
Last updated
2018-10-02

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02998957. Inclusion in this directory is not an endorsement.